Prothrombogenic factors and reduced antioxidative defense in children and adolescents with pre-metabolic and metabolic syndrome

被引:25
作者
Dimitrijevic-Sreckovic, Vesna
Colak, Emina
Djordjevic, Predrag
Gostiljac, Drasko
Sreckovic, Branko
Popovic, Srdjan
Canovic, Fadil
Ilic, Miroijub
Obrenovic, Radmila
Vukcevic, Vladan
Nikolic, Dragan
Nisic, Tanja
Milic, Gordana
Pejcic, Gordana
机构
[1] Clin Ctr Serbia, Inst Endocrinol Diab & Metab Dis, Belgrade, Serbia
[2] Clin Ctr Serbia, Inst Med Biochem, Belgrade, Serbia
[3] Clin Ctr Serbia, Inst Cardiovasc Dis, Belgrade, Serbia
关键词
antioxidative defense; children/adolescents; metabolic syndrome; plasminogen activator inhibitor-1; pre-metabolic syndrome;
D O I
10.1515/CCLM.2007.259
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The aim of this study was to examine prothrombogenic factors and antioxidative defense in obese children and adolescents with pre-metabolic and metabolic syndrome, and to analyze insulin secretion and resistance, early glycoregulation disorders and lipid status. Methods: Insulin sensitivity was determined using the homeostasis model assessment for insulin resistance (HOMA-IR), while insulin secretion was determined using the homeostasis model assessment beta (HOMA-beta). Prothrombogenic factors analyzed were plasma plasminogen activator inhibitor-1 (PAI-1) and fibrinogen. Superoxide dismutase and glutathione peroxdase were measured as markers of antioxidative defense. Results: Patients with metabolic syndrome were characterized with increased body mass index (BMI), waist circumference, and HOMA-IR and HOMA-beta levels, and all had increased blood pressure and triglyceride levels, low high-density lipoprotein cholesterol levels, increased PAI-1 levels and reduced antioxidative defense levels. Patients with pre-metabolic syndrome had higher levels of basal and mean insulinemia during an oral glucose tolerance test, higher levels of HOMA-beta and lower levels of antioxidative defense compared to patients with metabolic syndrome. Conclusions: Negative correlations between antioxidative defense parameters and BMI, abdominal obesity, insulin secretion, systolic blood pressure and atherogenic lipid factors, as well as correlations between PAI-1 and insulin resistance and basal glycemia in the metabolic syndrome group contribute to accelerated atherosclerosis. Positive correlations between PAI-1 and waist circumference and BMI, and negative correlations between BMI and antioxidative defense in the pre-metabolic syndrome patients show that this early stage preceding the metabolic syndrome is also characterized by atherosclerotic complication risks and evident hyperinsulinism and insulin resistance.
引用
收藏
页码:1140 / 1144
页数:5
相关论文
共 24 条
[1]  
[Anonymous], 2002, Diabetes care, V25, pS1
[2]  
BARCLAY L, 2005, ARCH PEDIAT ADOLESC, V159, P740
[3]  
Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.0.CO
[4]  
2-G
[5]   Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications [J].
Colak, E ;
Majkic-Singh, N ;
Stankovic, S ;
Sreckovic-Dimitrijevic, V ;
Djordjevic, PB ;
Lalic, K ;
Lalic, N .
ANNALS OF MEDICINE, 2005, 37 (08) :613-620
[6]   Prevalence of a metabolic syndrome phenotype in adolescents - Findings from the Third National Health and Nutrition Examination Survey, 1988-1994 [J].
Cook, S ;
Weitzman, M ;
Auinger, P ;
Nguyen, M ;
Dietz, WH .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2003, 157 (08) :821-827
[7]   The metabolic syndrome in children and adolescents [J].
Cruz M.L. ;
Goran M.I. .
Current Diabetes Reports, 2004, 4 (1) :53-62
[8]   Platelet activation in obese women -: Role of inflammation and oxidant stress [J].
Davì, G ;
Guagnano, MT ;
Ciabattoni, G ;
Basili, S ;
Falco, A ;
Marinopiccoli, M ;
Nutini, M ;
Sensi, S ;
Patrono, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2008-2014
[9]   Percentile distribution of the waist circumference among Mexican pre-adolescents of a primary school in Mexico City [J].
Gómez-Díaz, RA ;
Martínez-Hernández, AJ ;
Aguilar-Salinas, CA ;
Violante, R ;
López-Alarcón, M ;
Jiménez-Villarruel, M ;
Wacher-Rodarte, N ;
Solórzano-Santos, F .
DIABETES OBESITY & METABOLISM, 2005, 7 (06) :716-721
[10]  
GOUPAL NK, 2004, DIABETOLOGIA, V44, P706